This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1006/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73358292
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en febreru de 2000 article scientifique publié en février 2000 wetenschappelijk artikel scientific article published on 01 February 2000 im Februar 2000 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в лютому 2000 artikull shkencor i botuar më 01 shkurt 2000 wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch
p:P577
wds:Q73358292-CFD9F497-F03E-492C-8B74-0125E4ADA337
wdt:P577
2000-02-01T00:00:00Z
p:P2093
wds:Q73358292-D730CBCD-0DAA-4B14-8C25-4642130AD9DA wds:Q73358292-5D7D4750-3CE0-4A4F-9EF7-362DFED104F8 wds:Q73358292-1FEE7C73-51E8-476D-8E79-27FC658650A4 wds:Q73358292-3CA587E2-12F0-4135-A525-8DB32BACDCE0 wds:Q73358292-EF05271F-6047-425B-99DC-A3E19282F673
wdt:P2093
R J Schilder M Morgan C E Mangan J A Blessing J S Rader
rdfs:label
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group
skos:prefLabel
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group
schema:name
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group
p:P1476
wds:Q73358292-DDE9B230-D69D-423B-B3DA-A1A87391BA07
wdt:P1476
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group
p:P304
wds:Q73358292-85E6952D-D741-4FFA-AFF7-491A2240FBAA
wdt:P304
204-207
p:P31
wds:Q73358292-9B78F9F3-2A7F-46B5-AB64-2904657D2BF6
wdt:P31
wd:Q13442814
p:P921
wds:Q73358292-E701C457-0CE8-497A-91B2-6B484F6E2661 wds:Q73358292-547425F7-54EB-45AD-8AEB-E6B9BFD4E6DF
wdt:P921
wd:Q18556057 wd:Q5625186
p:P698
wds:Q73358292-B20ACC19-FDF9-4E8B-9ECA-0C9A1CABE9BF
wdtn:P698
n12:10637071
wdt:P698
10637071
p:P1433
wds:Q73358292-5A3FDEDC-52E7-43BA-9C2D-CFF43937C25C
wdt:P1433
wd:Q5625182
p:P433
wds:Q73358292-51AB618F-4E41-48C8-AAF7-C32A037FD7F7
p:P478
wds:Q73358292-17C17CC5-DAC2-425D-9C76-6EDAD289694C
wdt:P433
2
wdt:P478
76
p:P356
wds:Q73358292-8F9EE20E-DC32-4EFD-A3C8-6A783CF28E0E
wdtn:P356
n11:GYNO.1999.5671
wdt:P356
10.1006/GYNO.1999.5671